Home › Funds › Tyro Capital Management LLC › TRVI
Tyro Capital Management LLC position in TRVI
TREVI THERAPEUTICS INC · Health Care
Tyro Capital Management LLC reported holding 291,890 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.74% of its reported portfolio and ranking #24 among its reported holdings. Tyro Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Tyro Capital Management LLC's TRVI position evolved
Tyro Capital Management LLC first disclosed a stake in TRVI in Q3 2026 at 291,890 shares (US$4.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 291.89K | $4.18M | New |
About TRVI and 13F data
TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 65 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRVI
- NEA Management Company, LLC 13.22M sh · $246.59M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.94M sh · $185.37M · Q2 2026
- Vivo Capital, LLC 5.09M sh · $95.02M · Q2 2026
- Vestal Point Capital, LP 3.10M sh · $57.81M · Q2 2026
- MPM BioImpact LLC 3.07M sh · $57.32M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.66M sh · $49.61M · Q2 2026
- Artia Global Partners LP 2.21M sh · $41.23M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.14M sh · $40.00M · Q2 2026
- First Light Asset Management, LLC 2.10M sh · $39.11M · Q2 2026
- Logos Global Management LP 1.88M sh · $35.06M · Q2 2026
- Affinity Asset Advisors, LLC 1.80M sh · $33.57M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.74M sh · $32.50M · Q2 2026
More on Tyro Capital Management LLC
FAQ
How long has Tyro Capital Management LLC held TRVI?
Tyro Capital Management LLC has disclosed TRVI holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Tyro Capital Management LLC's current position in TRVI?
As of Q3 2026, Tyro Capital Management LLC holds 291.89K shares of TRVI (TREVI THERAPEUTICS INC), valued at $4.18M, representing 0.74% of its reported portfolio and ranking #24.
Has Tyro Capital Management LLC been buying or selling TRVI?
In the latest 13F filing (Q3 2026), Tyro Capital Management LLC newly opened its position in TRVI.
Which other funds hold TRVI?
Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.